Inhibitor preuzimanja (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Inhibitor preuzimanja" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
610th place
653rd place
archive.org
- Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K (2005). „The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study”. J Clin Psychiatry. 66 (11): 1401—8. PMID 16420077. doi:10.4088/JCP.v66n1109.
- Boissard CG, Gribkoff VK (1993). „The effects of the adenosine reuptake inhibitor soluflazine on synaptic potentials and population hypoxic depolarizations in area CA1 of rat hippocampus in vitro”. Neuropharmacology. 32 (2): 149—55. PMID 8383814. doi:10.1016/0028-3908(93)90095-K.
- Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G (2006). „AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain”. Br J Pharmacol. 148 (7): 1022—32. PMC 1751928
. PMID 16770320. doi:10.1038/sj.bjp.0706798.
doi.org
- Iversen L. (2006). „Neurotransmitter transporters and their impact on the development of psychopharmacology.”. Br J Pharmacol. 147 (1): S82—88. PMC 1760736 . PMID 16402124. doi:10.1038/sj.bjp.0706428.
- West AR, Galloway MP (1997). „Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study”. Neurosci Lett. 230 (1): 21—4. PMID 9259454. doi:10.1016/S0304-3940(97)00465-5.
- Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K (2005). „The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study”. J Clin Psychiatry. 66 (11): 1401—8. PMID 16420077. doi:10.4088/JCP.v66n1109.
- Alberati D; Moreau JL; Lengyel J; et al. (2012). „Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia”. Neuropharmacology. 62 (2): 1152—61. PMID 22138164. doi:10.1016/j.neuropharm.2011.11.008.
- Boissard CG, Gribkoff VK (1993). „The effects of the adenosine reuptake inhibitor soluflazine on synaptic potentials and population hypoxic depolarizations in area CA1 of rat hippocampus in vitro”. Neuropharmacology. 32 (2): 149—55. PMID 8383814. doi:10.1016/0028-3908(93)90095-K.
- Barkhimer TV, Kirchhoff JR, Hudson RA, Messer WS (2002). „Evaluation of the inhibition of choline uptake in synaptosomes by capillary electrophoresis with electrochemical detection”. Electrophoresis. 23 (21): 3699—704. PMID 12432531. doi:10.1002/1522-2683(200211)23:21<3699::AID-ELPS3699>3.0.CO;2-E.
- Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G (2006). „AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain”. Br J Pharmacol. 148 (7): 1022—32. PMC 1751928 . PMID 16770320. doi:10.1038/sj.bjp.0706798.
elsevier.com
linkinghub.elsevier.com
- Alberati D; Moreau JL; Lengyel J; et al. (2012). „Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia”. Neuropharmacology. 62 (2): 1152—61. PMID 22138164. doi:10.1016/j.neuropharm.2011.11.008.
nih.gov
ncbi.nlm.nih.gov
- Iversen L. (2006). „Neurotransmitter transporters and their impact on the development of psychopharmacology.”. Br J Pharmacol. 147 (1): S82—88. PMC 1760736 . PMID 16402124. doi:10.1038/sj.bjp.0706428.
- West AR, Galloway MP (1997). „Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study”. Neurosci Lett. 230 (1): 21—4. PMID 9259454. doi:10.1016/S0304-3940(97)00465-5.
- Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K (2005). „The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study”. J Clin Psychiatry. 66 (11): 1401—8. PMID 16420077. doi:10.4088/JCP.v66n1109.
- Alberati D; Moreau JL; Lengyel J; et al. (2012). „Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia”. Neuropharmacology. 62 (2): 1152—61. PMID 22138164. doi:10.1016/j.neuropharm.2011.11.008.
- Boissard CG, Gribkoff VK (1993). „The effects of the adenosine reuptake inhibitor soluflazine on synaptic potentials and population hypoxic depolarizations in area CA1 of rat hippocampus in vitro”. Neuropharmacology. 32 (2): 149—55. PMID 8383814. doi:10.1016/0028-3908(93)90095-K.
- Barkhimer TV, Kirchhoff JR, Hudson RA, Messer WS (2002). „Evaluation of the inhibition of choline uptake in synaptosomes by capillary electrophoresis with electrochemical detection”. Electrophoresis. 23 (21): 3699—704. PMID 12432531. doi:10.1002/1522-2683(200211)23:21<3699::AID-ELPS3699>3.0.CO;2-E.
- Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G (2006). „AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain”. Br J Pharmacol. 148 (7): 1022—32. PMC 1751928 . PMID 16770320. doi:10.1038/sj.bjp.0706798.